Crossmark

The fasting 13C-glucose breath test is a more sensitive evaluation method for diagnosing hepatic insulin resistance as a cardiovascular risk factor than HOMA-IR

Crossref DOI link: https://doi.org/10.1016/j.cca.2019.09.014

Published Print: 2020-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ezaki, Hirotaka https://orcid.org/0000-0003-1475-5001
Matsuura, Tomokazu

Ayaori, Makoto https://orcid.org/0000-0002-5644-3279
Ochi, Sae

Mezaki, Yoshihiro

Masaki, Takahiro https://orcid.org/0000-0001-9857-3453
Taniwaki, Masanori

Miyake, Takayuki

Sakurada, Masami

Ikewaki, Katsunori
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Uehara Memorial Foundation
License Information

Text and Data Mining valid from 2020-01-01

Text and Data Mining valid from 2020-01-01
More Information

This article is maintained by: Elsevier

Article Title: The fasting 13C-glucose breath test is a more sensitive evaluation method for diagnosing hepatic insulin resistance as a cardiovascular risk factor than HOMA-IR

Journal Title: Clinica Chimica Acta

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cca.2019.09.014

Content Type: article

Copyright: © 2019 Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below